نتایج جستجو برای: leukemia lymphocytic chronic b cell

تعداد نتایج: 2734448  

Journal: :iranian journal of public health 0
d.d. farhud h. sadighi l. andonian m. saffari

associations of some hematological and lymphatic diseases with sex and abo and rh blood groups were studied in 2579 patients, compared with a control group of 126332 individuals, by the use of clinical as well as laboratory findings, in tehran. highly significant increase of male/female ratio is shown in acute myelogenous leukemia, acute lymphocytic leukemia, chronic lymphocytic leukemia, aplas...

Acute lymphocytic leukemia (ALL) is one of the frequent malignancies in pediatrics and involves bone marrow and extramedullary sites. Proptosis as extramedullary involvement of leukemia usually present in acute and chronic myeloid leukemia. It is extremely rare for ALL to present initially as proptosis.Here, a-21-month-old boy was presented with proptosis without any associated symptoms except ...

2017
Martijn HA van Attekum Eric Eldering Arnon P Kater

The importance of the tumor microenvironment in chronic lymphocytic leukemia is widely accepted. Nevertheless, the understanding of the complex interplay between the various types of bystander cells and chronic lymphocytic leukemia cells is incomplete. Numerous studies have indicated that bystander cells provide chronic lymphocytic leukemia-supportive functions, but it has also become clear tha...

Journal: :Haematologica 2013
Alessandra Cesano Omar Perbellini Erik Evensen Charles C Chu Federica Cioffi Jason Ptacek Rajendra N Damle Roberto Chignola James Cordeiro Xiao-jie Yan Rachael E Hawtin Ilaria Nichele Jodi R Ware Chiara Cavallini Ornella Lovato Roberta Zanotti Kanti R Rai Nicholas Chiorazzi Giovanni Pizzolo Maria T Scupoli

While many prognostic markers in B-cell chronic lymphocytic leukemia provide insight into the biology of the disease, few have been demonstrated to be useful in the daily management of patients. B-cell receptor signaling is a driving event in the progression of B-cell chronic lymphocytic leukemia and markers of B-cell receptor responsiveness have been shown to be of prognostic value. Single cel...

Journal: :American Society of Clinical Oncology educational book 2021

At the time of writing, five anti-CD19 CAR T-cell products are approved by U.S. Food and Drug Administration for seven different indications in lymphoid malignancies, including B-cell non-Hodgkin lymphoma, pediatric acute lymphoblastic leukemia, multiple myeloma. T cells chronic lymphocytic myeloid less common malignancies such as lymphomas Hodgkin lymphoma being tested early-phase clinical tri...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Anna Vardi Andreas Agathangelidis Evangelia Stalika Maria Karypidou Alexandra Siorenta Achilles Anagnostopoulos Richard Rosenquist Anastasia Hadzidimitriou Paolo Ghia Lesley-Ann Sutton Kostas Stamatopoulos

PURPOSE The role of antigen(s) in shaping the T-cell repertoire in chronic lymphocytic leukemia, although relevant for understanding malignant cell interactions with cognate T cells, is largely unexplored. EXPERIMENTAL DESIGN Here we profiled the T-cell receptor β chain gene repertoire in 58 chronic lymphocytic leukemia patients, focusing on cases assigned to well-characterized subsets with s...

2017
Salma M AlDallal

Ofatumumab Arzerra® is a human monoclonal antibody, which induces killing of a panel of tumor B-cell lines and primary tumor cells by the activation of in vitro complement-dependent cytotoxicity and antibody-dependent, cell-mediated cytotoxicity. The humanized anti-CD20 monoclonal antibody has been approved by the US Food and Drug Administration for the treatment of chronic lymphocytic leukemia...

Journal: :Encyclopedia 2022

Genome-editing systems such as Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 technology have uncovered new opportunities to model diseases chronic lymphocytic leukemia. CRISPR/Cas9 is an important means of advancing functional studies Chronic Lymphocytic Leukemia (CLL) through the incorporation, elimination and modification somatic mutations in CLL models.

Journal: :Haematologica 2013
Davide Brusa Sara Serra Marta Coscia Davide Rossi Giovanni D'Arena Luca Laurenti Ozren Jaksic Giorgio Fedele Giorgio Inghirami Gianluca Gaidano Fabio Malavasi Silvia Deaglio

Chronic lymphocytic leukemia is marked by profound defects in T-cell function. Programmed death-1 is a receptor involved in tumor-mediated immunosuppression through binding of the PD-L1 ligand. Multiparametric flow cytometry and immunohistochemistry were used to study PD-1/PD-L1 expression. Functional assays were used to determine the involvement of the PD-1/PD-L1 axis in T-cell responses. PD-1...

Journal: :African Journal of Urology 2021

Abstract Background Richter’s syndrome is the transformation of indolent lymphoma into an aggressive form, most commonly diffuse large B cell lymphoma. Most patients are known to have chronic lymphocytic leukemia. arises in lymph nodes or bone marrow and rarely presents with extra nodal involvement. Case presentation Our patient presented at extremely uncommon site, i.e., testis. This fourth ca...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید